Abstract

The development of mucosal vaccines against pathogens is currently a highly explored area of research in both humans and animals. This is due to the fact that mucosal vaccines have the potential to best elicit protective responses at these mucosal surfaces, which represent the frontline of host defense, thus blocking the pathogen at its initial replication sites. However, in order to provide an efficient long-lasting protection, these mucosal vaccines have to be capable of eliciting an adequate systemic immune response in addition to local responses. In aquaculture, the need for mucosal vaccines has further practical implications, as these vaccines would avoid the individual manipulation of fish out of the water, being beneficial from both an economic and animal welfare point of view. However, how B and T cells are organized in teleost fish within these mucosal sites and how they respond to mucosally delivered antigens varies greatly when compared to mammals. For this reason, it is important to establish which mucosally delivered antigens have the capacity to induce strong and long-lasting B and T cell responses. Hence, in this review, we have summarized what is currently known regarding the adaptive immune mechanisms that are induced both locally and systemically in fish after mucosal immunization through different routes of administration including oral and nasal vaccination, anal intubation and immersion vaccination. Finally, based on the data presented, we discuss how mucosal vaccination strategies could be improved to reach significant protection levels in these species.

Highlights

  • Vaccination is a cost-efficient method to prevent the development of infectious diseases in humans and animals

  • In many of the studies mentioned through this work the levels of protection conferred by the vaccines have not been studied, it seems clear that those mucosal vaccines that are capable of eliciting strong systemic B and T cell responses are better suited to confer protection, and these are the ones we have focused on in this paper

  • Taking into account that pathogens enter the organisms through mucosal surfaces where they initiate their replication and having established that mucosal vaccines have a superior ability to trigger mucosal immunity than systemic vaccines, mucosal vaccines seem as a great alternative to vaccines administered through injection

Read more

Summary

Frontiers in Immunology

The development of mucosal vaccines against pathogens is currently a highly explored area of research in both humans and animals. This is due to the fact that mucosal vaccines have the potential to best elicit protective responses at these mucosal surfaces, which represent the frontline of host defense, blocking the pathogen at its initial replication sites. How B and T cells are organized in teleost fish within these mucosal sites and how they respond to mucosally delivered antigens varies greatly when compared to mammals For this reason, it is important to establish which mucosally delivered antigens have the capacity to induce strong and long-lasting B and T cell responses.

INTRODUCTION
LOCAL AND SYSTEMIC EFFECTS AFTER ORAL VACCINATION
Antibacterial Vaccines
Antiviral Vaccines
LOCAL AND SYSTEMIC EFFECTS AFTER IMMERSION VACCINATION
LOCAL AND SYSTEMIC EFFECTS AFTER NASAL VACCINATION
LOCAL AND SYSTEMIC EFFECTS AFTER ANAL INTUBATION
STRATEGIES FOR IMPROVING THE EFFICIENCY OF MUCOSAL VACCINATION IN TELEOST FISH
CONCLUDING REMARKS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call